Apros Therapeutics, Inc
1 clinical trials · Sponsor
◉ Watch Apros Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation Study of APR003 in Patients With Advanced Colorectal Cancer (CRC) With Malignant Liver Lesions (NCT04645797) | Apros Therapeutics, Inc | 2021-01-19 |
Track Apros Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.